KAYA, E. And YILMAZ, Y. Non-invasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease. 2024. In Metabolic Steatotic Liver Disease Current Knowledge, Therapeutic Treatments, and Future Directions , ELSEVIER, STANDFORD, 137-150.

KAYA, E., & YILMAZ, Y., (2024). Non-invasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease. Metabolic Steatotic Liver Disease Current Knowledge, Therapeutic Treatments, and Future Directions (pp.137-150), STANDFORD: ELSEVIER.

KAYA, EDA, And YUSUF YILMAZ. "Non-invasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease." In Metabolic Steatotic Liver Disease Current Knowledge, Therapeutic Treatments, and Future Directions , 137-150. STANDFORD: ELSEVIER, 2024

KAYA, EDA And YILMAZ, YUSUF. "Non-invasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease." Metabolic Steatotic Liver Disease Current Knowledge, Therapeutic Treatments, and Future Directions , ELSEVIER, 2024, pp.137-150.

KAYA, E. And YILMAZ, Y. (2024) "Non-invasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease", Metabolic Steatotic Liver Disease Current Knowledge, Therapeutic Treatments, and Future Directions . STANDFORD: ELSEVIER.

@bookchapter{bookchapter, author ={EDA KAYA And author ={YUSUF YILMAZ}, chaptertitle={Non-invasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease}, booktitle={ Metabolic Steatotic Liver Disease Current Knowledge, Therapeutic Treatments, and Future Directions}, publisher={ELSEVIER}, city={STANDFORD},year={2024} }